Department of Dermatology, Centre for Blistering Diseases, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, the Netherlands.
Br J Dermatol. 2011 Dec;165(6):1314-22. doi: 10.1111/j.1365-2133.2011.10553.x. Epub 2011 Nov 17.
Junctional epidermolysis bullosa, type Herlitz (JEB-H) is a lethal, autosomal recessive blistering disease caused by null mutations in the genes coding for the lamina lucida/densa adhesion protein laminin-332 (LAMB3, LAMA3 and LAMC2).
To present the diagnostic features and molecular analyses of all 22 patients with JEB-H in the Dutch Epidermolysis Bullosa Registry between 1988 and 2011, and to calculate the disease incidence and carrier frequency in the Netherlands.
All patients were analysed with immunofluorescence antigen mapping (IF), electron microscopy (EM) and molecular analysis.
The mean lifespan of our patients with JEB-H was 5·8 months (range 0·5-32·6). IF showed absent (91%) or strongly reduced (9%) staining for laminin-332 with monoclonal antibody GB3. In EM the hemidesmosomes and sub-basal dense plates were hypoplastic or absent. We identified mutations in all 22 patients: in 19 we found LAMB3 mutations, in two LAMA3 mutations, and in one LAMC2 mutations. We found three novel splice site mutations in LAMB3: (i) c.29-2A>G resulting in an out-of-frame skip of exon 3 and a premature termination codon (PTC); (ii) c.1289-2_1296del10 leading to an out-of-frame skip of exon 12 and a PTC; and (iii) c.3228+1G>T leading to an exon 21 skip.
All diagnostic tools should be evaluated to clarify the diagnosis of JEB-H. We have identified 11 different mutations in 22 patients with JEB-H, three of them novel. In the Netherlands the incidence rate of JEB-H is 4·0 per one million live births. The carrier frequency of a JEB-H mutation in the Dutch population is 1 in 249.
交界性大疱性表皮松解症,赫尔利兹型(JEB-H)是一种致命的常染色体隐性水疱性疾病,由编码层粘连蛋白-332(LAMB3、LAMA3 和 LAMC2)的基因中的无义突变引起。
介绍 1988 年至 2011 年间荷兰大疱性表皮松解症登记处中所有 22 例 JEB-H 患者的诊断特征和分子分析,并计算荷兰该病的发病率和携带者频率。
对所有患者进行免疫荧光抗原定位(IF)、电子显微镜(EM)和分子分析。
JEB-H 患者的平均寿命为 5.8 个月(范围 0.5-32.6)。IF 显示用单克隆抗体 GB3 对层粘连蛋白-332 的染色呈阴性(91%)或明显减少(9%)。EM 显示半桥粒和亚基底致密板发育不良或缺失。我们在所有 22 例患者中发现了突变:19 例患者发现 LAMB3 突变,2 例患者发现 LAMA3 突变,1 例患者发现 LAMC2 突变。我们在 LAMB3 中发现了三个新的剪接位点突变:(i)c.29-2A>G 导致外显子 3的无框架跳跃和提前终止密码子(PTC);(ii)c.1289-2_1296del10 导致外显子 12 的无框架跳跃和 PTC;和(iii)c.3228+1G>T 导致外显子 21 的跳跃。
应评估所有诊断工具以明确 JEB-H 的诊断。我们在 22 例 JEB-H 患者中发现了 11 种不同的突变,其中 3 种为新突变。在荷兰,JEB-H 的发病率为每百万活产儿 4.0。荷兰人群中 JEB-H 突变的携带者频率为 1 比 249。